Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1963 1
1964 3
1965 2
1967 2
1968 1
1969 2
1971 2
1972 4
1973 3
1975 1
1976 1
1977 1
1978 2
1979 1
1980 1
1982 1
1983 2
1985 1
1986 2
1987 2
1988 1
1989 3
1990 1
1991 1
1992 1
1993 2
1996 3
1997 2
1999 1
2003 2
2006 3
2007 1
2008 1
2009 1
2010 3
2011 1
2013 1
2014 4
2015 5
2016 3
2017 3
2018 5
2019 9
2020 6
2021 5
2022 5
2023 3
2024 8
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean pan c (9,659 results)?
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma.
Grisendi G, Dall'Ora M, Casari G, Spattini G, Farshchian M, Melandri A, Masciale V, Lepore F, Banchelli F, Costantini RC, D'Esposito A, Chiavelli C, Spano C, Spallanzani A, Petrachi T, Veronesi E, Ferracin M, Roncarati R, Vinet J, Magistri P, Catellani B, Candini O, Marra C, Eccher A, Bonetti LR, Horwtiz EM, Di Benedetto F, Dominici M. Grisendi G, et al. Among authors: spano c. Cell Rep Med. 2024 Aug 20;5(8):101685. doi: 10.1016/j.xcrm.2024.101685. Cell Rep Med. 2024. PMID: 39168103 Free PMC article.
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial.
Tonelli R, Pischiutta F, Elice F, Zanier ER, Grisendi G, Astori G, Samarelli AV, Bruzzi G, Manicardi L, Spano C, Nattino G, Signorini F, Bernardi M, Catanzaro D, Merlo A, Lisi I, Pasetto L, Bonetto V, Fiammenghi L, Boschi L, Guidi S, Candini O, Zoerle T, Dander E, D'Amico G, De Pierri F, Maur M, Pettorelli E, Ruggieri V, Cerri S, Mari G, De Berardis G, Mighali P, Baschieri MC, Lazzari L, Bambi F, Ciccocioppo R, Clini E, Dominici M; RESCAT study group. Tonelli R, et al. Among authors: spano c. Cytotherapy. 2025 Sep;27(9):1105-1115. doi: 10.1016/j.jcyt.2025.04.059. Epub 2025 Apr 7. Cytotherapy. 2025. PMID: 40353787 Free article. Clinical Trial.
GD2 expression in breast cancer.
Orsi G, Barbolini M, Ficarra G, Tazzioli G, Manni P, Petrachi T, Mastrolia I, Orvieto E, Spano C, Prapa M, Kaleci S, D'Amico R, Guarneri V, Dieci MV, Cascinu S, Conte P, Piacentini F, Dominici M. Orsi G, et al. Among authors: spano c. Oncotarget. 2017 May 9;8(19):31592-31600. doi: 10.18632/oncotarget.16363. Oncotarget. 2017. PMID: 28415563 Free PMC article.
Tumor Stroma Manipulation By MSC.
Grisendi G, Spano C, Rossignoli F, D Souza N, Golinelli G, Fiori A, Horwitz EM, Guarneri V, Piacentini F, Paolucci P, Dominici M. Grisendi G, et al. Among authors: spano c. Curr Drug Targets. 2016;17(10):1111-26. doi: 10.2174/1389450117666160307143226. Curr Drug Targets. 2016. PMID: 26953248 Review.
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma.
Golinelli G, Grisendi G, Dall'Ora M, Casari G, Spano C, Talami R, Banchelli F, Prapa M, Chiavelli C, Rossignoli F, Candini O, D'Amico R, Nasi M, Cossarizza A, Casarini L, Dominici M. Golinelli G, et al. Among authors: spano c. Transl Oncol. 2022 Jan;15(1):101240. doi: 10.1016/j.tranon.2021.101240. Epub 2021 Oct 12. Transl Oncol. 2022. PMID: 34649148 Free PMC article.
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma.
Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M. Chiavelli C, et al. Among authors: spano c. NPJ Precis Oncol. 2024 Feb 1;8(1):26. doi: 10.1038/s41698-024-00506-z. NPJ Precis Oncol. 2024. PMID: 38302615 Free PMC article.
Ivabradine versus bisoprolol.
Fazio G, Sarulo F, Licata P, D'Angelo L, Passantino S, Visconti C, Zarcone P, Spanò C, Novo G, Novo S. Fazio G, et al. Among authors: spano c. Minerva Cardioangiol. 2010 Apr;58(2):281-2. Minerva Cardioangiol. 2010. PMID: 20440257 No abstract available.
GD2 CAR T cells against human glioblastoma.
Prapa M, Chiavelli C, Golinelli G, Grisendi G, Bestagno M, Di Tinco R, Dall'Ora M, Neri G, Candini O, Spano C, Petrachi T, Bertoni L, Carnevale G, Pugliese G, Depenni R, Feletti A, Iaccarino C, Pavesi G, Dominici M. Prapa M, et al. Among authors: spano c. NPJ Precis Oncol. 2021 Oct 27;5(1):93. doi: 10.1038/s41698-021-00233-9. NPJ Precis Oncol. 2021. PMID: 34707200 Free PMC article.
117 results